FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

GR Skinner

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Procedures

Co-author Network

Publications

TOP 3
GR Skinner; A Ahmad; JA Davies
The infrequency of transmission of herpesviruses between humans and animals; postulation of an unrecognised protective host mechanism.
GR Skinner; A Ahmad; A Zafar; M G Hullin; D Dick
Prophylaxis against staphylococcal infection before tertiary knee joint replacement.
GR Skinner; JA Davies; S Dundarov; P Andonov
Prevention of herpes genitalis by the 'Bulgarian' vaccine F.HSV-2V(PRK): preliminary clinical evidence.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of GR Skinner (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2001: GR Skinner; A Ahmad; JA Davies
The infrequency of transmission of herpesviruses between humans and animals; postulation of an unrecognised protective host mechanism.
Comparative immunology, microbiology and infectious diseases 2001;24(4):255-69.
2001: GR Skinner; A Ahmad; A Zafar; M G Hullin; D Dick
Prophylaxis against staphylococcal infection before tertiary knee joint replacement.
Orthopedics 2001;24(3):289-91.
2000: GR Skinner; JA Davies; S Dundarov; P Andonov
Prevention of herpes genitalis by the 'Bulgarian' vaccine F.HSV-2V(PRK): preliminary clinical evidence.
Croatian medical journal 2000;41(4):378-83.
2000: O T Elekima; Charles O Mills; A Ahmad; GR Skinner; D B Ramsden; JA Bown; Tom W Young; Elwyn Elias
Reduced hepatic content of dehydroepiandrosterone sulphotransferase in chronic liver diseases.
Liver 2000;20(1):45-50.
2000: GR Skinner; J Davies
Efficacy of an inactivated vaccine for equine herpesvirus type 1 in a novel hamster model.
Intervirology 2000;43(1):27-35.
1998: GR Skinner; M Billstrom; S Randall; A Buchan; J Davies; A Ahmad
Antiviral efficacy of disinfectant solution MRI-1.
Intervirology 1998;41(6):238-43.
1998: J Benitez; A Ahmad; J Davies; GR Skinner
Environmental influence on immune inhibition of release of herpes simplex virus from cells.
Intervirology 1998;41(2-3):120-6.
1998: C E Bolt; JA Davies; S Randall; GR Skinner
The influence of the milieu on the rate of neutralisation of herpes simplex virus 1.
Archives of virology 1998;143(3):549-56.
1997: GR Skinner; M E Turyk; C A Benson; G D Wilbanks; P Heseltine; J Galpin; R Kaufman; L Goldberg; C E Hartley; A Buchan
The efficacy and safety of Skinner herpes simplex vaccine towards modulation of herpes genitalis; report of a prospective double-blind placebo-controlled trial.
Medical microbiology and immunology 1997;186(1):31-6.
1997: GR Skinner; M A Billstrom; S Randall; A Ahmad; S Patel; J Davies; A Deane
A system for isolation, transport and storage of herpes simplex viruses.
Journal of virological methods 1997;65(1):1-8.
1996: GR Skinner; J Davies; A Ahmad; P McLeish; A Buchan
An outbreak of herpes rugbiorum managed by vaccination of players and sociosexual contacts.
The Journal of infection 1996;33(3):163-7.
1996: H M Goodyear; J A Davies; P McLeish; A Buchan; GR Skinner; M Winther; J I Harper
Growth of herpes simplex type 1 on skin explants of atopic eczema.
Clinical and experimental dermatology 1996;21(3):185-9.
1996: A Ahmad; J Davies; S Randall; GR Skinner
Antiviral properties of extract of Opuntia streptacantha.
Antiviral research 1996;30(2-3):75-85.
1996: H M Goodyear; P McLeish; S Randall; A Buchan; GR Skinner; M Winther; J Rolland; G Morgan; J I Harper
Immunological studies of herpes simplex virus infection in children with atopic eczema.
The British journal of dermatology 1996;134(1):85-93.
1994: J Davies; J A Hallworth; P McLeish; S Randall; B A Martin; A Buchan; GR Skinner
Characterization and immunogenicity of a candidate subunit vaccine against varicella-zoster virus.
Medical microbiology and immunology 1994;183(2):105-17.
1994: GR Skinner; J A Davies; M Sheasby; N Mahmood
Early studies on a candidate intracellular subunit vaccine NFU.Ac.HIV[JM] for prevention and/or modification of HIV-related disease.
Intervirology 1994;37(5):259-68.
1993: C E Hartley; A Buchan; S Randall; GR Skinner; M Osborne; L M Tomkins
The effects of lithium and potassium on macromolecular synthesis in herpes simplex virus-infected cells.
The Journal of general virology 1993;74 ( Pt 8)():1519-25.
1993: M A Billstrom; J A Davies; A Buchan; GR Skinner
Development of subunit preparations of cytomegalovirus antigen by aqueous extraction for immunization against cytomegalovirus infection.
Intervirology 1993;36(1):20-31.
1992: GR Skinner; C Fink; J Melling; C Wiblin; B Thornton; J Hallworth; W Gardner; P McLeish; C Hartley; A Buchan
Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.
Medical microbiology and immunology 1992;180(6):305-20.
1992: GR Skinner; J Davies; M A Billstrom; A Buchan
In vivo model for evaluation of species-specific virus vaccines.
Vaccine 1992;10(12):847-51.
1991: M E O'Brien; BE Souberbielle; M E Cowan; C A Allen; David M Luesley; J J Mould; George Blackledge; GR Skinner
Glycoprotein patterns in normal and malignant cervical tissue.
Cancer letters 1991;58(3):247-54.
1991: D M Shariff; J Davies; M Desperbasques; M Billstrom; H J Geerligs; Gjalt W Welling; Sytske Welling-Wester; A Buchan; GR Skinner
Immune inhibition of virus release from human and nonhuman cells by antibody to viral and host cell determinants.
Intervirology 1991;32(1):28-36.
1991: GR Skinner; A Buchan; J Davies; Jennifer Durham; G Castrucci
A virus-particle vaccine prepared from bovine mammillitis virus against herpes genitalis.
Comparative immunology, microbiology and infectious diseases 1991;14(2):133-50.
1990: A Ahmad; S Clarke; A Buchan; GR Skinner
Sequential release of antigens from chloroform-treated Staphylococcus epidermidis: application towards a possible vaccine.
The Journal of applied bacteriology 1990;69(5):676-85.
1990: M Cowan; J Davies; K Brookes; M Billstrom; P McLeish; A Buchan; GR Skinner
Inhibition of rate of tumour growth in rodent species by inoculation of herpesviruses and encephalomyocarditis virus.
Journal of medical virology 1990;30(3):211-5.
1988: GR Skinner; M Cowan; J Davies; K Brookes; M Billstrom; A Buchan
Reduced tumorigenicity of rodent tumour cells and tumour explants following infection with wild type and mutant herpes simplex virus, bovine mammillitis virus and encephalomyocarditis virus.
British journal of experimental pathology 1988;69(4):495-504.
1988: A Manning; A Buchan; GR Skinner; Jennifer Durham; H Thompson
The immunological relationship between canine herpesvirus and four other herpesviruses.
The Journal of general virology 1988;69 ( Pt 7)():1601-8.
1988: M E Cowan; GR Skinner
Cervical carcinoma: an experimental approach.
Cancer surveys 1988;7(3):469-79.
1988: D M Shariff; J Hallworth; M Desperbasques; A Buchan; GR Skinner
Immune inhibition of virus release from herpes simplex virus-infected cells by human sera.
Intervirology 1988;29(3):125-32.
1988: J A Hallworth; D I Stocker; D Shariff; D Sugrue; A Buchan; GR Skinner
Humoral antibody response in patients with herpes genitalis: analysis of factors influencing the pattern of disease.
Medical microbiology and immunology 1988;177(3):145-59.
1987: GR Skinner; A Buchan; Jennifer Durham; M Cowan; J Davies; K Brookes; G Castrucci
Role of bovine mammillitis virus towards preparation of an alternative vaccine against herpes simplex virus infections of human subjects.
Vaccine 1987;5(1):55-9.
1987: GR Skinner; C G Fink; M Cowan; A Buchan; A Oveta Fuller; C E Hartley; Jennifer Durham; C Wiblin; J Melling
Follow-up report on 50 subjects vaccinated against herpes genitalis with Skinner vaccine.
Medical microbiology and immunology 1987;176(3):161-8.
1987: D Shariff; J A Hallworth; A Buchan; GR Skinner
Irreproducibility of neutralization of herpes simplex virus under conditions where antibody is not in excess.
Intervirology 1987;28(2):100-4.
1987: E M Muniu; Jennifer Durham; D Shariff; C E Hartley; A Oveta Fuller; J Melling; C Wiblin; G Wilkins; A Buchan; GR Skinner
Antibody reactivity with Skinner HSV vaccine.
Medical microbiology and immunology 1987;176(6):315-27.
1986: M H Chen; Z Zhou; C E Hartley; M Cowan; GR Skinner
Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
Vaccine 1986;4(4):249-52.
1985: A Buchan; GR Skinner; A Oveta Fuller; C Hartley; J Hallworth; D Stocker; J Melling; C Wiblin
Control of herpes simplex virus infections of the genital tract by vaccination.
Vaccine 1985;3(1):49-53.
1985: P J Holmes; J A Hallworth; D I Stocker; GR Skinner
Augmentation of the neutralisation test for type 1 HSV: evidence of high representation of neutralising antibody in the adult community.
Medical microbiology and immunology 1985;174(4):167-75.
1983: M H Chen; C Y Dong; Z H Liu; GR Skinner; C E Hartley
Prevention of type 2 herpes simplex virus induced cervical carcinoma in mice by prior immunization with a vaccine prepared from type 1 herpes simplex virus.
Vaccine 1983;1(1):13-6.
1983: C B Woodman; A Buchan; A Oveta Fuller; C Hartley; GR Skinner; D Stocker; D Sugrue; J C Clay; G Wilkins; C Wiblin
Efficacy of vaccine Ac NFU1 (S-) MRC 5 given after an initial clinical episode in the prevention of herpes genitalis.
The British journal of venereal diseases 1983;59(5):311-3.
1983: C B Woodman; D Stocker; D Sugrue; M Desberbasques; C E Hartley; A Oveta Fuller; A Buchan; GR Skinner
The relative infrequency and low levels of neutralising and immunoprecipitating antibody to herpes simplex viruses types 1 and 2 in patients with a history of recurrent herpes genitalis.
Medical microbiology and immunology 1983;171(4):243-50.
1982: GR Skinner; C B Woodman; C E Hartley; A Buchan; A Oveta Fuller; Jennifer Durham; M Synnott; J C Clay; J Melling; C Wiblin; J Wilkins
Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
The British journal of venereal diseases 1982;58(6):381-6.
1982: M E Cowan; K Ward; C B Woodman; GR Skinner
Polypeptide synthesis in columnar and squamous explants of human uterine cervix.
British journal of experimental pathology 1982;63(5):472-8.
1982: M E Cowan; A Buchan; GR Skinner
Synthesis of immunoglobulins by human endocervix in organ culture.
British journal of experimental pathology 1982;63(2):125-32.
1982: D Cox; S L Hawkins; C E Hartley; M J Mylotte; GR Skinner
Antibody activity against herpes simplex virus in human amniotic fluid.
British journal of obstetrics and gynaecology 1982;89(3):226-30.
1982: GR Skinner; C Woodman; C Hartley; A Buchan; A Oveta Fuller; C Wiblin; G Wilkins; J Melling
Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis.
Developments in biological standardization 1982;52():333-44.
1981: C A Carter; C E Hartley; GR Skinner; S P Turner; D L Easty
Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.
The British journal of ophthalmology 1981;65(10):679-82.
1981: S P Turner; C E Hartley; A Buchan; GR Skinner
Preparation and efficacy of an inactivated subunit vaccine against Aujeszky's disease virus infection.
Research in veterinary science 1981;31(2):261-3.
1980: GR Skinner; A Buchan; C E Hartley; S P Turner; D R Williams
The preparation, efficacy and safety of 'antigenoid' vaccine NFU1 (S-L+) MRC toward prevention of herpes simplex virus infections in human subjects.
Medical microbiology and immunology 1980;169(1):39-51.